December 8 Meeting Scheduled to Discuss 6 Studies Showing Increased Risk of Blood Clots
The FDA will hold hearings next month to consider the risks of blood clots associated with Yaz, Yasmin, Ocella, and Beyaz. Although approximately six studies now show an increased risk, the FDA has not yet determined whether to officially update the warnings on these pills. The agency is widely expected to make a decision at or shortly ...
continue reading...